| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/28/2001 | US6281006 Detecting proteins and nucleic acids; electrode coated with redox polymer; biochemical immobilization |
| 08/28/2001 | US6280988 Method for detecting Candida infection |
| 08/28/2001 | US6280977 Method for generating transcriptionally active DNA fragments |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/28/2001 | US6280967 Detecting particles which generate cellular response; mix cell suspension with modulators, pass through detection zone and measure preferential cellular responses |
| 08/28/2001 | US6280966 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 08/28/2001 | US6280965 Attaching peptide or protein substrate to well plate, washing with buffer; adding reaction buffer; adding protein kinase c, agitation, adding nulceotide to phosphorylate; incubation; washing; forming solution; measuring color intensity |
| 08/28/2001 | US6280954 Using primer to amplify nucleic acid; providing array of probes; applying fragments of amplifier nucleic acid under hybridisation conditions to array for enzymatic chain extension; observing location probes of array |
| 08/28/2001 | US6280953 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 08/28/2001 | US6280952 Mixing capture probe with sample containing target polynucleotide at hybridization condition; incubating mixture containing capture probe, target polynucleotide complex and immobilized probe; purifying captured target by washing |
| 08/28/2001 | US6280951 Monitoring parathyroid hormone activity in humans; determine genotype of parathyroid receptor, the presence of preferential polymorphism indicates an amplification in parathyroid activity |
| 08/28/2001 | US6280950 Nucleic acid affinity columns |
| 08/28/2001 | US6280949 Multiple displacement amplification |
| 08/28/2001 | US6280948 Classification of polynucleotides in sample; mixing nucleotide sequences and adaptors, incubate and amplify polynucleotides, recover and classify nucleotide sequences |
| 08/28/2001 | US6280947 Methods for detecting nucleotide insertion or deletion using primer extension |
| 08/28/2001 | US6280946 Peptide nucleic acid probes for the detection of microorganisms in sample |
| 08/28/2001 | US6280945 Low temperature method for determining the presence or absence of a nucleic acid in sample; bind biotinylated oligonucleotide to solid phase support and incubate with nucleic acid sample, detect hybridization product |
| 08/28/2001 | US6280943 As diagnostic agents |
| 08/28/2001 | US6280941 Detecting preferential genetic disorder; recover tissue sample, amplify nucleic acids, detect amplification product of preferential size, the presence of preferential amplification product indicates genetic disorder |
| 08/28/2001 | US6280940 Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
| 08/28/2001 | US6280939 Method and apparatus for DNA sequencing using a local sensitive force detector |
| 08/28/2001 | US6280938 SCA7 gene and method of use |
| 08/28/2001 | US6280935 Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags |
| 08/28/2001 | US6280934 Assay for agents which alter G-protein coupled receptor activity |
| 08/28/2001 | US6280933 Multichromophore fluorescent probes using DNA intercalation complexes |
| 08/28/2001 | US6280932 High affinity nucleic acid ligands to lectins |
| 08/28/2001 | US6280931 Method for specifically amplifying a dystroglycan, α-sarcoglycan, or endothelin Breceptor cDNA of an extremely small |
| 08/28/2001 | US6280930 Deactivating enzymatic polypeptide; incubate nucleotide sequences with probes and amplification enzyme, amplify target nucleic acid sequences, denature nucleotide sequences, heat sample and detect amplified target sequences |
| 08/28/2001 | US6280929 Stain target chromosomal nucleotide sequences to detect genetic rearangements associated with genetic disorders; provide heterogenous nucleotide probes, mix with targeted chromosomal sequences, monitor for sequences rearrangements |
| 08/28/2001 | US6280928 Mixed cell diagnostic systems |
| 08/28/2001 | US6280926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same |
| 08/28/2001 | US6280735 Polypeptides of riboflavin specific deaminase family |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | US6280618 Multiplex flow assays preferably with magnetic particles as solid phase |
| 08/28/2001 | US6280590 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
| 08/28/2001 | US6280587 Enzyme electrode and a biosensor and a measuring apparatus therewith |
| 08/28/2001 | US6280586 Measuring device using biological cells or chemical biologically active substances contained in an analyte |
| 08/28/2001 | CA2333930A1 Dna sequence encoding the specific and antigenic outer membrane protein of s amonella typhi |
| 08/28/2001 | CA2173872C Telomerase activity assays |
| 08/28/2001 | CA2107552C Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/25/2001 | CA2337562A1 Diagnostics based on tetrazolium compounds |
| 08/24/2001 | CA2338138A1 A method for production of a transgenic animal, and a transgenic animal produced by the method |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061355A1 Molecular impriniting compositions and methods for binding and analyzing macromolecules |
| 08/23/2001 | WO2001061354A1 Compositions and methods for surface imprinting |
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061052A1 Dna arrays for determining drug selectivity |
| 08/23/2001 | WO2001061051A1 Methods for peptide-based cdna characterization and analysis |
| 08/23/2001 | WO2001061050A2 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 08/23/2001 | WO2001061048A2 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 08/23/2001 | WO2001061045A1 Functionalized encapsulated fluorescent nanocrystals |
| 08/23/2001 | WO2001061044A1 Data analysis and display system for ligation-based dna sequencing |
| 08/23/2001 | WO2001061043A2 Parallel genotyping of multiple patient samples |
| 08/23/2001 | WO2001061042A2 Composite membranes for assaying biomolecules |
| 08/23/2001 | WO2001061041A2 Multiple-site reaction device and method |
| 08/23/2001 | WO2001061040A1 Microarray methods utilizing semiconductor nanocrystals |
| 08/23/2001 | WO2001061039A2 5-hydroxytryptamine transporter gene polymorphisms |
| 08/23/2001 | WO2001061038A2 Method for detecting a biological entity in a sample |
| 08/23/2001 | WO2001061037A1 Methods and kits for proximity probing |
| 08/23/2001 | WO2001061036A2 A method of mapping restriction endonuclease cleavage sites |
| 08/23/2001 | WO2001061035A1 Method for detecting a mycobacterium tuberculosis specific intein and use in diagnosis of tuberculosis |
| 08/23/2001 | WO2001061034A1 A homogenous method for detection of a polynucleotide, with e.g. cleavable lanthanide chelate label |
| 08/23/2001 | WO2001061033A2 Multiplex ligatable probe amplification |
| 08/23/2001 | WO2001061031A2 Improved assay for protein tyrosine phosphatases |
| 08/23/2001 | WO2001061030A2 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION |
| 08/23/2001 | WO2001061029A2 Identification method |
| 08/23/2001 | WO2001061028A2 Methods and products for peptide based dna sequence identification and analysis |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060995A1 Cell fusion assays using fluorescence resonance energy transfer |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060989A1 Blood serum or plasma stabilization system |
| 08/23/2001 | WO2001060988A2 Biotechnologically interesting proteins from cat sharks |
| 08/23/2001 | WO2001060982A1 Genetically engineered skin cell types and toxicity assays |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060970A2 Zinc finger domains and methods of identifying same |
| 08/23/2001 | WO2001060860A2 Genes differentially expressed in human prostate cancer and their use |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060856A2 Vmglom gene and its mutations causing disorders with a vascular component |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060769A1 Segment synthesis |
| 08/23/2001 | WO2001060408A2 Microcompetiton and human disease |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001060401A1 Methods of modulating protease-activated receptor-4 (par4) activation via cathepsin g |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060174A2 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | WO2001023600A3 Methods of ranking oligonucleotides for specificity using wash dissociation histories |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001013115A3 Method and device for identifying a biopolymer sequence on a solid surface |
| 08/23/2001 | WO2001013086A3 Detection of nucleic acids |
| 08/23/2001 | WO2001012851A3 Identification of genetic markers of biological age and metabolism |
| 08/23/2001 | WO2001012796A3 PKD constructs and screening methods |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |